EN
TR
Single-center and reverse evaluation of febrile neutropenic attacks of patients followed with acute myeloid leukemia diagnosis
Abstract
Aim: Since fever may be the only symptom in patients with hematological malignancy, fever in neutropenic patients is considered to be related to infection until proven otherwise. The standard approach is the rapid evaluation of febrile neutropenic (FEN) episodes and initiation of appropriate antibiotic treatment. In this study, it was aimed to examine the duration of FEN, infection categories, symptoms and examination findings, isolated microorganisms and mortality rates of the patients we followed up in our clinic due to acute myeloid leukemia.
Materials and Methods: We examined 155 adult patients with AML who were treated at the Adult Hematology Clinic. In our study, we retrospectively evaluated 337 chemotherapy-related FEN episodes in terms of infection categories, offending pathogenic microorganisms and mortality rates.
Results: 43.92% (n=148) of the patients had pathological examination findings accompanying the fever. FEN attacks in 249 patients had clinically and/or microbiologically proven foci of infection. The most frequent infection site was the lungs (41.5%). The most frequently isolated microorganisms were found to be coagulase negative staphylococcus (37.30%) and E.coli (36.21%). 32.94% of the patients (n=111) were recorded as smokers. When the relationship between smoking and lung infection was investigated, it was determined that the incidence of lung infection was higher in smokers (p= 0.007). In 91 (27%) of those who had a FEN attack in our hospital resulted in death. It was the lung infection that mostly correlated with the mortality (40.71%).
Conclusion: Each clinic can determine empirical antibiotic treatment policies by investigating infectious agents. It can manage the FEN episode process more accurately by providing the necessary infection control measures.
Keywords
Etik Beyan
Bu çalışmaya Ege üniversitesi Tıp Fakültesi Klinik Araştırmalar etik kurulu tarafından etik onay verilmiştir.
Kaynakça
- Link H, Böhme A, Cornely OA, Höffken K, Kellner O, Kern WV, et al. Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 2003; 82 Suppl 2:S105-17.
- Febril Nötropeni Çalışma Grubu. Febril Nötropenik Hastalarda Tanı ve Tedavi Kılavuzu. Flora 2004; 9(1): 5- 28.
- Trecarichi EM, Tumbarello M. Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact. Curr Opin Infect Dis 2014; 27:200-10.
- Gardner A, Mattiuzzi G, Faderl S, Borthakur G, Garcia-Manero G, Pierce S, et al. Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia. J Clin Oncol 2008; 26:5684-8.
- Gupta A, Singh M, Singh H, Kumar L, Sharma A, Bakhshi S, et al. Infections in acute myeloid leukemia: an analysis of 382 febrile episodes. Med Oncol 2010; 27:1037-45.
- Ediger D, Uzaslan EK, Yüksel EG. Evaluation of pneumonia cases in intensive care unit. Turkiye Klinikleri Archives Lung. 2005;6:111–4. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;302:1872–9.
- Cetintepe T, Cetintepe L, Solmaz S, Calık S, Ugur MC, Gediz F, et. al. Determination of the relationship between mortality and SOFA, qSOFA, MASCC scores in febrile neutropenic patients monitored in the intensive care unit. Support Care Cancer. 2021; 29(7): 4089–4094.
- Gil L, Poplawski D, Mol A, Nowicki A, Schneider A, Komarnicki M. Neutropenic enterocolitis after high-dose chemotherapy and autologous stem cell transplantation: incidence, risk factors, and outcome. Transpl Infect Dis. 2013;15(1):1-7.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Hematoloji , İç Hastalıkları
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
12 Mart 2025
Gönderilme Tarihi
25 Mart 2024
Kabul Tarihi
19 Aralık 2024
Yayımlandığı Sayı
Yıl 2025 Cilt: 64 Sayı: 1